Pillemer SR, Bradley LA, Crofford LJ, Moldofsky H, Chrousos GP: The neuroscience and endocrinology of fibromyalgia. Arthritis Rheum. 1997, 40: 1928-1939.
CAS
PubMed
Google Scholar
Lautenbacher S, Rollman GB: Possible deficiencies of pain modulation in fibromyalgia. Clin J Pain. 1997, 13: 189-196. 10.1097/00002508-199709000-00003.
CAS
PubMed
Google Scholar
Bennett RM: Emerging concepts in the neurobiology of chronic pain: evidence of abnormal sensory processing in fibromyalgia. Mayo Clin Proc. 1999, 74: 385-398.
CAS
PubMed
Google Scholar
Staud R: Evidence of involvement of central neural mechanisms in generating fibromyalgia pain. Curr Rheumatol Rep. 2002, 4: 299-305.
PubMed
Google Scholar
Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al: The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990, 33: 160-172.
CAS
PubMed
Google Scholar
Bennett RM: Emerging concepts in the neurobiology of chronic pain: evidence of abnormal sensory processing in fibromyalgia. Mayo Clin Proc. 1999, 74: 385-398.
CAS
PubMed
Google Scholar
Baranauskas G, Nistri A: Sensitization of pain pathways in the spinal cord: cellular mechanisms. Prog Neurobiol. 1998, 54: 349-365. 10.1016/S0301-0082(97)00067-1.
CAS
PubMed
Google Scholar
Basbaum AI, Fields HL: Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci. 1984, 7: 309-338. 10.1146/annurev.ne.07.030184.001521.
CAS
PubMed
Google Scholar
Clark FM, Proudfit HK: The projections of noradrenergic neurons in the A5 catecholamine cell group to the spinal cord in the rat: anatomical evidence that A5 neurons modulate nociception. Brain Res. 1993, 616: 200-210. 10.1016/0006-8993(93)90210-E.
CAS
PubMed
Google Scholar
Millan MJ: Descending control of pain. Prog Neurobiol. 2002, 66: 355-474. 10.1016/S0301-0082(02)00009-6.
CAS
PubMed
Google Scholar
Russell IJ, Vaeroy H, Javors M, Nyberg F: Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum. 1992, 35: 550-556.
CAS
PubMed
Google Scholar
Russell IJ, Michalek JE, Vipraio GA, Fletcher EM, Javors MA, Bowden CA: Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol. 1992, 19: 104-109.
CAS
PubMed
Google Scholar
Yunus MB, Dailey JW, Aldag JC, Masi AT, Jobe PC: Plasma tryptophan and other amino acids in primary fibromyalgia: a controlled study. J Rheumatol. 1992, 19: 90-94.
CAS
PubMed
Google Scholar
Coderre TJ, Katz J: Peripheral and central hyperexcitability: differential signs and symptoms in persistent pain. Behav Brain Sci. 1997, 20: 404-19. 10.1017/S0140525X97251484.
CAS
PubMed
Google Scholar
Legangneux E, Mora JJ, Spreux-Varoquaux O, Thorin I, Herrou M, Alvado G, Gomeni C: Cerebrospinal fluid biogenic amine metabolites, plasma-rich platelet serotonin and [3H]imipramine reuptake in the primary fibromyalgia syndrome. Rheumatology (Oxford). 2001, 40: 290-296. 10.1093/rheumatology/40.3.290.
CAS
Google Scholar
Arnold LM, Keck PE, Welge JA: Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics. 2000, 41: 104-113. 10.1176/appi.psy.41.2.104.
CAS
PubMed
Google Scholar
Carette S, McCain GA, Bell DA, Fam AG: Evaluation of amitriptyline in primary fibrositis: A double-blind, placebo-controlled study. Arthritis Rheum. 1986, 29: 655-659.
CAS
PubMed
Google Scholar
Carette S, Bell MJ, Reynolds WJ, Haraoui B, McCain GA, Bykerk VP, Edworthy SM, Baron M, Koehler BE, Fam AG, et al: Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia: A randomized, double-blind clinical trial. Arthritis Rheum. 1994, 37: 32-40.
CAS
PubMed
Google Scholar
Carette S, Oakson G, Guimont C, Steriade M: Sleep electroencephalography and the clinical response to amitriptyline in patients with fibromyalgia. Arthritis Rheum. 1995, 38: 1211-1217.
CAS
PubMed
Google Scholar
Goldenberg DL, Mayskiy M, Mossey C, Ruthazer R, Schmid C: A randomized double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum. 1996, 39: 1852-1859.
CAS
PubMed
Google Scholar
Caruso I, Puttini PCS, Boccassini L, Santandrea S, Locati M, Volpato R, Montrone F, Benvenuti C, Beretta A: Double-blind study of dothiepin versus placebo in the treatment of primary fibromyalgia syndrome. J Int Med Res. 1987, 15: 154-159.
CAS
PubMed
Google Scholar
Bennett RM, Gatter RA, Campbell SM, Andrews RP, Clark SR, Scarola JA: A comparison of cyclobenzaprine and placebo in the management of fibrositis. Arthritis Rheum. 1988, 31: 1535-1542.
CAS
PubMed
Google Scholar
Quimby LG, Gratwick GM, Whitney CD, Block SR: A randomized trial of cyclobenzaprine for the treatment of fibromyalgia. J Rheumatol. 1989, 16 (Suppl 19): 140-143.
Google Scholar
Reynolds WJ, Moldofsky H, Saskin P, Lue FA: The effects of cyclobenzaprine on sleep physiology and symptoms in patients with fibromyalgia. J Rheumatol. 1991, 18: 452-454.
CAS
PubMed
Google Scholar
Kobayashi H, Hasegawa Y, One H: Cyclobenzaprine, a centrally acting muscle relaxant, acts on descending serotonergic systems. Eur J Pharmacol. 1996, 311: 29-35. 10.1016/0014-2999(96)00402-5.
CAS
PubMed
Google Scholar
Bibolotti E, Borghi C, Pasculli E, Regoli F, Tavoni A, Baroni L, Castrogiovanni P, Pasero G: The management of fibrositis: A double-blind comparison of maprotiline (Ludiomil), chlorimipramine, and placebo. J Clin Trials. 1986, 23: 269-280.
Google Scholar
Tofferi JK, Jackson JL, O'Malley PG: Treatment of fibromyalgia with cyclobenzaprine: A meta-analysis. Arthritis Rheum. 2004, 51: 9-13. 10.1002/art.20076.
CAS
PubMed
Google Scholar
O'Malley PG, Balden E, Tomkins G, Santoro J, Kroenke K, Jackson JL: Treatment of fibromyalgia with antidepressants. A meta-analysis. J Gen Intern Med. 2000, 15: 659-666. 10.1046/j.1525-1497.2000.06279.x.
PubMed Central
PubMed
Google Scholar
Hannonen P, Malminiemi K, Yli-Kerttula U, Isomeri R, Rokponen P: A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder. Br J Rheumatol. 1998, 37: 1279-1286. 10.1093/rheumatology/37.12.1279.
CAS
PubMed
Google Scholar
Scudds RA, McCain GA, Rollman GB, Harth M: Improvements in pain responsiveness in patients with fibrositis after successful treatment with amitriptyline. J Rheumatol. 1989, 16 (Suppl 19): 98-103.
Google Scholar
Ginsberg F, Mancaux A, Joos E, Vanhove P, Famaey JP: A randomized placebo-controlled trial of sustained-release amitriptyline in primary fibromyalgia. J Musculoskeletal Pain. 1996, 4: 37-47. 10.1300/J094v04n03_05.
Google Scholar
Kempenears CH, Simenon G, Vander Elst M, Fransolet L, Mingard P, de Maertelaer V: Effect of an antidiencephalon immune serum on pain and sleep in primary fibromyalgia. Neuropsychobiology. 1994, 30: 66-72.
Google Scholar
Wolfe F, Cathey MA, Hawley DJ: A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol. 1994, 23: 255-259.
CAS
PubMed
Google Scholar
Nørregaard J, Volkmann H, Danneskiold-Samsoe B: A randomized controlled trial of citalopram in the treatment of fibromyalgia. Pain. 1995, 61: 445-449. 10.1016/0304-3959(94)00218-4.
PubMed
Google Scholar
Tavoni A, Vitali C, Bombardieri S, Pasero G: Evaluation of S-adenosylmethionine in primary fibromyalgia. Am J Med. 1987, 83 (Suppl 5A): 107-110. 10.1016/0002-9343(87)90862-X.
CAS
PubMed
Google Scholar
Jacobsen S, Danneskiold-Samsoe B, Andersen RB: Oral S-adenosylmethionine in primary fibromyalgia. Double-blind clinical evaluation. Scand J Rheumatol. 1991, 20: 294-302.
CAS
PubMed
Google Scholar
Anderberg UM, Marteinsdottir I, von Knorring L: Citalopram in patients with fibromyalgia – a randomized, double-blind, placebo-controlled study. Eur J Pain. 2000, 4: 27-35. 10.1053/eujp.1999.0148.
CAS
PubMed
Google Scholar
Bymaster FP, Zhang W, Carter PA, Shaw J, Chernet E, Phebus L, Won DT, Perry KW: Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Psychopharmacology. 2002, 160: 353-361. 10.1007/s00213-001-0986-x.
CAS
PubMed
Google Scholar
Nemeroff CB, Owens MJ: Neuropharmacology of paroxetine. Psychopharmacol Bull. 2003, 37 (Suppl 1): 8-18.
PubMed
Google Scholar
Arnold LM, Hess EV, Hudson JI, Welge JA, Berno SE, Keck PE: A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med. 2002, 112: 191-197. 10.1016/S0002-9343(01)01089-0.
CAS
PubMed
Google Scholar
Patkar AA, Peindl K, Krulewicz S, Mannelli P, Lindsay A, Masand PS: History of depressive and anxiety disorders as predictors of response in fibromyalgia. Presented at the 158th Annual Meeting of the American Psychiatric Association. 2005, NR 382, [http://www.psych.org]
Google Scholar
Goldenberg DL, Burckhardt C, Crofford L: Management of fibromyalgia syndrome. JAMA. 2004, 292: 2388-2395. 10.1001/jama.292.19.2388.
CAS
PubMed
Google Scholar
Beliles K, Stoudemire A: Psychopharmacologic treatment of depression in the medically ill. Psychosomatics. 1998, 39: S2-S19.
CAS
PubMed
Google Scholar
Dwight MM, Arnold LM, O'Brien H, Metzger R, Morris-Park E, Keck PE: An open clinical trial of venlafaxine in fibromyalgia. Psychosomatics. 1998, 39: 14-17.
CAS
PubMed
Google Scholar
Sayar K, Aksu G, Ak I, Tosun M: Venlafaxine treatment of fibromyalgia. Ann Pharmacother. 2003, 37: 1561-1565. 10.1345/aph.1D112.
CAS
PubMed
Google Scholar
Zijlstra TR, Barendregt PJ, van de Laar MAF: Venlafaxine in fibromyalgia: Results of a randomized, placebo-controlled, double-blind trial. Presented at the 66th Annual Meeting of the American College of Rheumatology. 2002, abstract 179, [http://www.rheumatology.org]
Google Scholar
Bymaster FP, Dreshfield-Ahmad LJ, Threlkeld PG, Shaw JL, Thompson L, Nelson DL, Hemrick-Luecke SK, Wong DT: Comparative affinity of duloxetine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology. 2001, 25: 871-880. 10.1016/S0893-133X(01)00298-6.
CAS
PubMed
Google Scholar
Goldstein DJ, Mallinckrodt C, Lu Y, Demitrack MA: Duloxetine in the treatment of major depressive disorder: A double-blind clinical trial. J Clin Psychiatry. 2002, 63: 225-231.
CAS
PubMed
Google Scholar
Detke MJ, Lu Y, Goldstein DJ, Hayes JR, Demitrack MA: Duloxetine 60 mg once daily for major depressive disorder: A randomized double-blind placebo-controlled trial. J Clin Psychiatry. 2002, 63: 308-315.
CAS
PubMed
Google Scholar
Detke MJ, Lu Y, Goldstein DJ, McNamara RK, Demitrack MA: Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression. J Psychiatr Res. 2002, 36: 383-390. 10.1016/S0022-3956(02)00060-2.
PubMed
Google Scholar
Goldstein DJ, Lu Y, Detke MJ, Hudson J, Iyengar S, Demitrack MA: Effects of duloxetine on painful physical symptoms associated with depression. Psychosomatics. 2004, 45: 17-28. 10.1176/appi.psy.45.1.17.
CAS
PubMed
Google Scholar
Raskin J, Pritchett YL, Wang F, D'Souza DN, Waninger AL, Iyengar S, Wernicke JF: A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med. 2005, 6: 346-356. 10.1111/j.1526-4637.2005.00061.x.
PubMed
Google Scholar
Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S: Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain. 2005, 116: 109-118. 10.1016/j.pain.2005.03.029.
CAS
PubMed
Google Scholar
Physicians' Desk Reference. 2006, Montvale, New Jersey: Thomson PDR
Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ: A double-blind, multicenter trial comparing duloxetine to placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum. 2004, 50: 2974-2984. 10.1002/art.20485.
CAS
PubMed
Google Scholar
Burckhardt CS, Clark SR, Bennett RM: The Fibromyalgia Impact Questionnaire: Development and validation. J Rheumatol. 1991, 18: 728-734.
CAS
PubMed
Google Scholar
Cleeland CS, Ryan KM: Pain assessment: global use of the brief pain inventory. Ann Acad Med. 1994, 23: 129-138.
CAS
Google Scholar
Fischer AA: Pressure threshold meter: its use for quantification of tender spots. Arch Phys Med Rehabil. 1986, 67: 836-838.
CAS
PubMed
Google Scholar
Guy W: ECDEU Assessment Manual for Psychopharmacology, Revised. US Department of Health, Education, and Welfare publication (ADM). 1976, Rockville, MD: National Institute of Mental Health, 76-338.
Google Scholar
Hunt SM, McKenna SP: The QLDS: a scale for the measurement of quality of life in depression. Health Policy. 1992, 22: 307-319. 10.1016/0168-8510(92)90004-U.
CAS
PubMed
Google Scholar
Sheehan DV, Harnett-Sheehan K, Raj BA: The measurement of disability. Int Clin Psychopharmacol. 1996, 11 (Suppl 3): 89-95.
PubMed
Google Scholar
Ware JE, Sherbourne CD: The SF-36 health status survey: I. Conceptual framework and item selection. Medical Care. 1992, 30: 473-483.
PubMed
Google Scholar
Arnold LM, Rosen A, Pritchett YL, D'Souza DN, Goldstein DJ, Iyengar S, Wernicke JF: A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain. 2005, 119: 5-15. 10.1016/j.pain.2005.06.031.
CAS
PubMed
Google Scholar
Kranzler JD, Gendreau JF, Rao SG: The psychopharmacology of fibromyalgia: a drug development perspective. Psychopharmacol Bull. 2002, 36: 165-213.
PubMed
Google Scholar
Gendreau RM, Thorn MD, Gendreau JF, Kranzler JD, Ribeiro S, Gracely RH, Williams DA, Mease PJ, McLean SA, Clauw DJ: Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol. 2005, 32: 1975-1985.
CAS
PubMed
Google Scholar
Melzack R: The McGill Pain Questionnaire: Major properties and scoring methods. Pain. 1975, 1: 277-299. 10.1016/0304-3959(75)90044-5.
CAS
PubMed
Google Scholar
Crofford LJ, Rowbotham MC, Mease PJ, Russell IJ, Dworkin RH, Corbin AE, Young JP, LaMoreaux LK, Martin SA, Sharma U, the Pregabalin 1008-105 Study Group: Pregabalin for the treatment of fibromyalgia syndrome. Results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2005, 52: 1264-1273. 10.1002/art.20983.
CAS
PubMed
Google Scholar
Melzack R: The short-form McGill Pain Questionnaire. Pain. 1987, 30: 191-197. 10.1016/0304-3959(87)91074-8.
CAS
PubMed
Google Scholar
Hays RD, Stewart AL: Sleep measures. Measuring Functioning and Well-being. Edited by: Stewart AL, Ware JEJ. 1992, Durham, NC: Duke University Press, 232-259.
Google Scholar
Belza B, Henke C, Epstein W, Gilliss C: Correlates of fatigue in older adults with rheumatoid arthritis. Nurs Res. 1993, 42: 93-99.
CAS
PubMed
Google Scholar
Zigmond A, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983, 67: 361-370.
CAS
PubMed
Google Scholar
Hindmarch I, Dawson J, Stanley N: A double-blind study in healthy volunteers to assess the effects on sleep of pregabalin compared with alprazolam and placebo. Sleep. 2005, 28: 187-193.
PubMed
Google Scholar
Drewes AM, Andreasen A, Jennum P, Nielsen KD: Zopiclone in the treatment of sleep abnormalities in fibromyalgia. Scand J Rheumatol. 1991, 20: 288-293.
CAS
PubMed
Google Scholar
Grönblad M, Nykänen J, Konttinen Y, Jarvinen E, Helve T: Effect of zopiclone of sleep quality, morning stiffness, widespread tenderness and pain and general discomfort in primary fibromyalgia patients. A double-blind randomized trial. Clin Rheumatol. 1993, 12: 186-191. 10.1007/BF02231524.
PubMed
Google Scholar
Moldofsky H, Lue FA, Mously C, Roth-Schechter B, Reynolds WJ: The effect of zolpidem in patients with fibromyalgia: a dose ranging, double-blind, placebo controlled, modified crossover study. J Rheumatol. 1996, 23: 529-533.
CAS
PubMed
Google Scholar
Russell IJ, Fletcher EM, Michalek JE, McBroom PC, Hester GG: Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam. Arthritis Rheum. 1991, 34: 552-560.
CAS
PubMed
Google Scholar
Quijada-Carrera J, Valenzuela-Castano A, Povedano-Gomez J, Fernandez-Rodriguez A, Hernanz-Mediano W, Gutierrez-Rubio A, de la Iglesia-Salgado JL, Garcia-Lopez A: Comparison of tenoxicam and bromazepan in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial. Pain. 1996, 65: 221-225. 10.1016/0304-3959(95)00199-9.
CAS
PubMed
Google Scholar
Scharf MB, Baumann M, Berkokwitz D: The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia. J Rheumatol. 2003, 30: 1070-1074.
CAS
PubMed
Google Scholar
Russell IJ, Bennett RM, Michalek JE, Oxybate for FMS Study Group: Sodium oxybate relieves pain and improves sleep in fibromyalgia syndrome [FMS]: A randomized, double-blind, placebo-controlled, multi-center clinical trial. Presented at the 69th Annual Meeting of the American College of Rheumatology. 2005, abstract 80, [http://www.rheumatology.org]
Google Scholar
Nicholson KL, Balster RL: GHB: a new and novel drug of abuse. Drug Alcohol Depend. 2001, 63: 1-22. 10.1016/S0376-8716(00)00191-5.
CAS
PubMed
Google Scholar
Griffiths RR, Johnson MW: Relative abuse liability of hypnotic drugs: A conceptual framework and algorithm for differentiating among compounds. J Clin Psychiatry. 2005, 66 (Suppl 9): 31-41.
CAS
PubMed
Google Scholar
Fuller DE, Hornfeldt CS, Kelloway JS, Stahl PJ, Anderson TF: The Xyrem® Risk Management Program. Drug Safety. 2004, 27: 293-306. 10.2165/00002018-200427050-00002.
CAS
PubMed
Google Scholar
Foldvary-Schaefer N, De Leon Sanchez I, Karafa M, Mascha E, Dinner D, Morris HH: Gabapentin increases slow-wave sleep in normal adults. Epilepsia. 2002, 43: 1493-1497. 10.1046/j.1528-1157.2002.21002.x.
CAS
PubMed
Google Scholar
Wolfe F, Anderson J, Harkness D, Bennett RM, Caro XJ, Goldenberg DL, Russell IJ, Yunus MB: A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum. 1997, 40: 1560-1570.
CAS
PubMed
Google Scholar
Sorensen J, Bengtsson A, Backman E, Henricksson KG, Ekselius L, Bengtsson M: Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine. Scand J Rheumatol. 1995, 24: 360-365.
CAS
PubMed
Google Scholar
Kemple KL, Smith G, Wong-Ngan J: Opioid therapy in fibromyalgia- A four year prospective evaluation of therapy selection, efficacy, and predictors of outcome. Arthritis Rheum. 2003, 48: S88-
Google Scholar
Chu LF, Clark DJ, Angst MS: Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: A preliminary prospective study. J Pain. 2006, 7: 43-48. 10.1016/j.jpain.2005.08.001.
CAS
PubMed
Google Scholar
King T, Gardell LR, Wang R, Vardanyan A, Ossipov MH, Malan TP, Vanderah TW, Hunt SP, Hruby VJ, Lai J, Porreca F: Role of NK-1 neurotransmission in opioid-induced hyperalgesia. Pain. 2005, 116: 276-288. 10.1016/j.pain.2005.04.014.
PubMed Central
CAS
PubMed
Google Scholar
Biasi G, Manca S, Manganelli S, Marcolongo R: Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo. Int J Clin Pharmacol Res. 1998, 18: 13-19.
CAS
PubMed
Google Scholar
Russell IJ, Kamin M, Bennett RM, Schnitzer TJ, Green JA, Katz WA: Efficacy of tramadol in treatment of pain in fibromyalgia. J Clin Rheumatol. 2000, 6: 250-257. 10.1097/00124743-200010000-00003.
CAS
PubMed
Google Scholar
Bennett RM, Kamin M, Karim R, Rosenthal N: Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: A double-blind, randomized, placebo-controlled study. Am J Med. 2003, 114: 537-545. 10.1016/S0002-9343(03)00116-5.
CAS
PubMed
Google Scholar
Bennett RM, Schein J, Kosinski MR, Hewitt DJ, Jordan DM, Rosenthal NR: Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen. Arthritis Rheum. 2005, 53: 519-527. 10.1002/art.21319.
PubMed
Google Scholar
Senay EC, Adams EH, Geller A, Inciardi JA, Munoz A, Schnoll SH, Woody GE, Cicero TJ: Physical dependence on Ultram® (tramadol hydrochloride): Both opioid-like and atypical withdrawal symptoms occur. Drug Alcohol Depend. 2003, 69: 233-241. 10.1016/S0376-8716(02)00321-6.
PubMed
Google Scholar
Farber L, Stratz T, Bruckle W, Spath M, Pongratz D, Lautenschlager J, Kotter I, Zoller B, Peter HH, Neeck G, Alten R, Muller W: Efficacy and tolerability of tropisetron in primary fibromyalgia-a highly selective and competitive 5-HT3 receptor antagonist. Scand J Rheumatol Suppl. 2000, 113: 49-54.
CAS
PubMed
Google Scholar
Spath M, Stratz T, Neeck G, Kotter I, Hammel B, Amberger CC, Haus U, Farber L, Pongratz D, Muller W: Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia. Scand J Rheumatol. 2004, 33: 267-270. 10.1080/03009740410005818.
CAS
PubMed
Google Scholar
Rao SG: The neuropharmacology of centrally-acting analgesic medications in fibromyalgia. Rheum Dis Clin North Am. 2002, 28: 235-259. 10.1016/S0889-857X(01)00004-7.
PubMed
Google Scholar
Henriksson KG, Sörensen J: The promise of N-methyl-D-aspartate receptor antagonists in fibromyalgia. Rheum Dis Clin North Am. 2002, 28: 343-351. 10.1016/S0889-857X(01)00013-8.
PubMed
Google Scholar
Clark SR, Bennett RM: Supplemental dextromethorphan in the treatment of fibromyalgia. A double blind, placebo controlled study of efficacy and side effects. Arthritis Rheum. 2000, 43: S333-
Google Scholar
Staud R, Vierck CJ, Robinson ME, Price DD: Effects of the N-Methyl-D-Aspartate receptor antagonist dextromethorphan on temporal summation of pain are similar in fibromyalgia patients and normal control subjects. J Pain. 2005, 6: 323-332. 10.1016/j.jpain.2005.01.357.
CAS
PubMed
Google Scholar
Holman AJ, Myers RR: A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum. 2005, 52: 2495-2505. 10.1002/art.21191.
CAS
PubMed
Google Scholar
Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L: The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995, 38: 19-28.
CAS
PubMed
Google Scholar
Rossy LA, Buckelew SP, Dorr N, Hagglund KJ, Thayer JF, McIntosh MJ, Hewett JE, Johnson JC: A meta-analysis of fibromyalgia treatment interventions. Ann Behav Med. 1999, 21: 180-191.
CAS
PubMed
Google Scholar
Hadhazy VA, Ezzo J, Creamer P, Berman BM: Mind-body therapies for the treatment of fibromyalgia. A systematic review. J Rheumatol. 2000, 27: 2911-2918.
CAS
PubMed
Google Scholar
Burckhardt CS, Mannerkorpi K, Hedenberg L, Bjelle A: A randomized, controlled clinical trial of education and physical training for women with fibromyalgia. J Rheumatol. 1994, 21: 714-720.
CAS
PubMed
Google Scholar
Vlaeyen JW, Teeken-Gruben NJ, Goossens ME, Rutten-van Molken MP, Pelt RA, van Eek H, Heuts PH: Cognitive-educational treatment of fibromyalgia: a randomized clinical trial. I. Clinical effects. J Rheumatol. 1996, 23: 1237-1245.
CAS
PubMed
Google Scholar
Martin L, Nutting A, MacIntosh BR, Edworthy SM, Butterwick D, Cook J: An exercise program in the treatment of fibromyalgia. J Rheumatol. 1996, 23: 1050-1053.
CAS
PubMed
Google Scholar
Wigers SH, Stiles TC, Vogel PA: Effects of aerobic exercise versus stress management treatment in fibromyalgia. Scand J Rheumatol. 1996, 25: 77-86.
CAS
PubMed
Google Scholar
Nicassio PM, Radojevic V, Weisman MH, Schuman C, Kim J, Schoenfeld-Smith K, Krall T: A comparison of behavioral and educational interventions for fibromyalgia. J Rheumatol. 1997, 24: 2000-2007.
CAS
PubMed
Google Scholar
Sim J, Adams N: Systematic review of randomized controlled trials of nonpharmacological interventions for fibromyalgia. Clin J Pain. 2002, 18: 324-336. 10.1097/00002508-200209000-00008.
PubMed
Google Scholar
Karjalainen KA, Hurri H, Jauhiainen M, Koes BW, Malmivaara A, Roine R, van Tulder M: Multidisciplinary rehabilitation for fibromyalgia and musculoskeletal pain in working age adults. Cochrane Database Syst Rev. 1999, Art. No.: CD001984. DOI: 10.1002/14651858.CD001984, 3
Google Scholar
Busch A, Schachter CL, Peloso PM, Bombardier C: Exercise for treating fibromyalgia syndrome. Cochrane Database Syst Rev. 2002, Art. No.: CD003786. DOI: 10.1002/14651858.CD003786, 2
Google Scholar
McCain GA, Bell DA, Mai FM, Halliday PD: A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia. Arthritis Rheum. 1988, 31: 1135-1141.
CAS
PubMed
Google Scholar
Mengshoel AM, Komnaes HB, Forre O: The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clin Exp Rheumatol. 1992, 10: 345-349.
CAS
PubMed
Google Scholar
Buckelew CS, Conway R, Parker J, Deuser WE, Read J, Witty TE, Hewett JE, Minor M, Johnson JC, Van Male L, et al: Biofeedback/relaxation training and exercise interventions for fibromyalgia: a prospective trial. Arthritis Care Res. 1998, 11: 196-209.
CAS
PubMed
Google Scholar
Hakkinen A, Hakkinen K, Hannonen P, Alen M: Strength training induced adaptations in neuromuscular function of premenopausal women with fibromyalgia: comparison with healthy women. Ann Rheum Dis. 2001, 60: 21-26. 10.1136/ard.60.1.21.
PubMed Central
CAS
PubMed
Google Scholar
Gowans SE, deHueck A, Voss S, Richardson M: A randomized, controlled trial of exercise and education for individuals with fibromyalgia. Arthritis Care Res. 1999, 12: 120-128. 10.1002/1529-0131(199904)12:2<120::AID-ART7>3.0.CO;2-4.
CAS
PubMed
Google Scholar
van Santen M, Bolwijn P, Verstappen F, Bakker C, Hidding A, Houben H, van der Heijde D, Landewe R, van der Linden S: A randomized clinical trial comparing fitness and biofeedback training versus basic treatment in patients with fibromyalgia. J Rheumatol. 2002, 29: 575-581.
PubMed
Google Scholar
van Santen M, Bolwijn P, Landewe R, Verstappen F, Bakker C, Hidding A, van der Heijde D, Houben H, van der Linden S: High or low intensity aerobic fitness training in fibromyalgia: Does it matter?. J Rheumatol. 2002, 29: 582-587.
PubMed
Google Scholar
Richards SCM, Scott DL: Prescribed exercise in people with fibromyalgia: parallel group randomized controlled trial. BMJ. 2002, 325: 185-188. 10.1136/bmj.325.7357.185.
PubMed Central
PubMed
Google Scholar
Schachter CL, Busch AJ, Peloso PM, Sheppard MS: Effects of short versus long bouts of aerobic exercise in sedentary women with fibromyalgia: A randomized controlled trial. Phys Ther. 2003, 83: 340-358.
PubMed
Google Scholar
Da Costa D, Abrahamowicz M, Lowensteyn I, Bernatsky S, Drista M, Fitzcharles MA, Dobkin PL: A randomized clinical trial of an individualized home-based exercise programme for women with fibromyalgia. Rheumatology. 2005, 44: 1422-1427. 10.1093/rheumatology/kei032.
CAS
PubMed
Google Scholar
Valim V, Oliveira L, Suda A, Silva L, de Assis M, Neto TB, Feldman D, Natour J: Aerobic fitness effects in fibromyalgia. J Rheumatol. 2003, 30: 1060-1069.
PubMed
Google Scholar
Mannerkorpi K, Nyberg B, Ahlmen M, Ekdahl C: Pool exercises combined with an education program for patients with fibromyalgia syndrome. A prospective, randomized study. J Rheumatol. 2000, 27: 2473-2481.
CAS
PubMed
Google Scholar
Mannerkorpi K, Ahlmen M, Ekdahl C: Six- and 24-month follow-up of pool exercise therapy and education for patients with fibromyalgia. Scand J Rheumatol. 2002, 31: 306-310. 10.1080/030097402760375223.
PubMed
Google Scholar
Cedraschi C, Desmeules J, Rapiti E, Baumgartner E, Cohen P, Finckh A, Allaz AF, Vischer TL: Fibromyalgia: A randomized, controlled trial of a treatment programme based on self management. Ann Rheum Dis. 2004, 63: 290-296. 10.1136/ard.2002.004945.
PubMed Central
CAS
PubMed
Google Scholar
King SJ, Wessel J, Bhambhani Y, Sholter D, Maksymowych W: The effects of exercise and education, individually or combined, in women with fibromyalgia. J Rheumatol. 2002, 29: 2620-2627.
PubMed
Google Scholar
Jones KD, Burckhardt CS, Clark SR, Bennett RM, Potempa KM: A randomized controlled trial of muscle strengthening versus flexibility training in fibromyalgia. J Rheumatol. 2002, 29: 1041-1048.
PubMed
Google Scholar
Kingsley JD, Panton LB, Toole T, Sirithienthad P, Mathis R, McMillan V: The effects of a 12-week strength-training program on strength and functionality in women with fibromyalgia. Arch Phys Med Rehabil. 2005, 86: 1713-1721. 10.1016/j.apmr.2005.04.014.
PubMed
Google Scholar
Dobkin PL, Abrahamowicz M, Fitzcharles MA, Dritsa M, Da Costa D: Maintenance of exercise in women with fibromyalgia. Arthritis Rheum. 2005, 53: 724-731. 10.1002/art.21470.
PubMed
Google Scholar
Oliver K, Cronan T: Predictors of exercise behaviors among fibromyalgia patients. Prev Med. 2002, 35: 383-389. 10.1006/pmed.2002.1084.
PubMed
Google Scholar
Williams DA, Cary MA, Groner KH, Chaplin W, Glazer LJ, Rodriguez AM, Clauw DJ: Improving physical functional status in patients with fibromyalgia: A brief cognitive behavioral intervention. J Rheumatol. 2002, 29: 1280-1286.
PubMed
Google Scholar
Kashikar-Zuck S, Swain NF, Jones BA, Graham TB: Efficacy of cognitive-behavioral intervention for juvenile primary fibromyalgia syndrome. J Rheumatol. 2005, 32: 1594-1602.
PubMed
Google Scholar
Edinger JD, Wohlgemuth WK, Krystal AD, Rice JR: Behavioral insomnia therapy for fibromyalgia patients. A randomized clinical trial. Arch Intern Med. 2005, 165: 2527-2535. 10.1001/archinte.165.21.2527.
PubMed
Google Scholar
Astin JA, Berman BM, Bausell B, Lee WL, Hochberg M, Forys KL: The efficacy of mindfulness meditation plus Qigong movement therapy in the treatment of fibromyalgia: A randomized controlled trial. J Rheumatol. 2003, 30: 2257-2262.
PubMed
Google Scholar
Oliver K, Cronan TA, Walen HR, Tomita M: Effects of social support and education on health care costs for patients with fibromyalgia. J Rheumatol. 2001, 28: 2711-2719.
CAS
PubMed
Google Scholar
Holdcraft LC, Assefi N, Buchwald D: Complementary and alternative medicine in fibromyalgia and related syndromes. Best Pract Res Clin Rheumatol. 2003, 17: 667-683. 10.1016/S1521-6942(03)00037-8.
PubMed
Google Scholar
Harris RE, Tian X, Williams DA, Tian TX, Cupps TR, Petzke F, Groner KH, Biswas P, Gracely RH, Clauw DJ: Treatment of fibromyalgia with formula acupuncture: Investigation of needle placement, needle stimulation, and treatment frequency. J Altern Complement Med. 2005, 11: 663-671. 10.1089/acm.2005.11.663.
PubMed
Google Scholar
Assefi NP, Sherman KJ, Jacobsen C, Goldberg J, Smith WR, Buchwald D: A randomized clinical trial of acupuncture compared with sham acupuncture in fibromyalgia. Ann Intern Med. 2005, 143: 10-19.
PubMed
Google Scholar
Williams DA: Psychological and behavioural therapies in fibromyalgia and related syndromes. Best Pract Res Clin Rheumatol. 2003, 17: 649-665. 10.1016/S1521-6942(03)00034-2.
PubMed
Google Scholar
Goldenberg DL, Burckhardt C, Crofford L: Management of fibromyalgia syndrome. JAMA. 2004, 292: 2388-2395. 10.1001/jama.292.19.2388.
CAS
PubMed
Google Scholar
Arnold LM, Hudson JI, Keck PE, Auchenbach MB, Hess EV: Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry.
Arnold LM: Systemic therapies for chronic pain. Fibromyalgia and Other Central Pain Syndromes. Edited by: Wallace DJ, Clauw DJ. 2005, Philadelphia, PA: Lippincott Williams & Wilkins, 365-388.
Google Scholar